Delay in diagnosis of epithelial ovarian cancer

被引:49
|
作者
Wikborn, C [1 ]
Pettersson, F [1 ]
Moberg, PJ [1 ]
机构
[1] KAROLINSKA SJUKHUSET,RADIUM HEMMET,DEPT GYNECOL ONCOL,STOCKHOLM,SWEDEN
关键词
ovarian cancer; patient delay; doctor delay;
D O I
10.1016/0020-7292(95)02588-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To investigate and analyze the process from first recognition of symptom(s) to final diagnosis at operation in patients with ovarian epithelial cancer. Method: The medical records of 160 women with ovarian cancer were studied and traced back to the doctor first consulted, in order to obtain information on patient- and doctor-related delay. Results: Symptom duration was 12 weeks in patients with serous tumors and 7 weeks in patients with other histopathological classes; 56% were diagnosed within 4 weeks. Women in stages I and II were diagnosed faster than those in stages III and IV; 4% were diagnosed within 3 days because of an emergency operation; 30% were not diagnosed within 8 weeks. Conclusion: Diagnosis of ovarian cancer is difficult due to the vagueness of the symptoms which mislead both patients and doctors. Methods to enable earlier diagnosis must be sought.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 50 条
  • [41] Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer
    Sawiris, GP
    Sherman-Baust, CA
    Becker, KG
    Cheadle, C
    Teichberg, D
    Morin, PJ
    CANCER RESEARCH, 2002, 62 (10) : 2923 - 2928
  • [42] Recommendation of the Polish Society of Oncological Gynaecology on the diagnosis and treatment of epithelial ovarian cancer
    Basta, Antoni
    Bidzinski, Mariusz
    Bienkiewicz, Andrzej
    Blecharz, Pawel
    Bodnar, Lubomir
    Jach, Robert
    Knapp, Pawel
    Kojs, Zbigniew
    Kotarski, Jan
    Markowska, Janina
    Misiek, Marcin
    Sznurkowski, Jacek
    Wicherek, Lukasz
    Sawicki, Wlodzimierz
    Timorek, Agnieszka
    Bahyrycz, Jan
    Madry, Radoslaw
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (05): : 233 - 243
  • [43] MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS
    Minareci, Yagmur
    Naziye, A. K.
    Sozen, Hamdullah
    Tosun, Ozgur Aydin
    Kucukgergin, Canan
    Aydin, Fatih
    Bingul, Ilknur
    Salihoglu, Yavuz Mehmet
    Topuz, Samet
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A242 - A242
  • [44] PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer
    Chai, Hong-Juan
    Ren, Qing
    Fan, Qin
    Ye, Liu
    Du, Guang-Ye
    Du, Hua-Wen
    Xu, Wei
    Li, Yue
    Zhang, Lan
    Cheng, Zhong-Ping
    ONCOLOGY LETTERS, 2017, 14 (05) : 5871 - 5875
  • [45] Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer
    Naniwa, J.
    Kigawa, J.
    Kanamori, Y.
    Itamochi, H.
    Oishi, T.
    Shimada, M.
    Shimogai, R.
    Kawaguchi, W.
    Sato, S.
    Terakawa, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) : 76 - 82
  • [46] Prevalence of ovarian endometriosis in epithelial ovarian cancer
    Jimbo, H
    Yoshikawa, H
    Onda, T
    Yasugi, T
    Sakamoto, A
    Taketani, Y
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1997, 59 (03) : 245 - 250
  • [47] Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
    Nanez, Andrea
    Stram, Douglas A.
    Powell, C. Bethan
    Garcia, Christine
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 39
  • [48] DELAY IN THE DIAGNOSIS OF CANCER
    LEACH, JE
    ROBBINS, GF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1947, 135 (01): : 5 - 8
  • [49] DELAY IN CANCER DIAGNOSIS
    WIGGINS, WS
    HILFINGER, MF
    BERMAN, LG
    NEW YORK STATE JOURNAL OF MEDICINE, 1951, 51 (05) : 626 - 628
  • [50] Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay
    Chase, Dana M.
    Neighbors, Jordan
    Perhanidis, Jessica
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2021, 161 (03) : 832 - 837